title: The treatment of urinary incontinence with Duloxetine.
abstract: Duloxetine is a Serotonin and Noradrenaline reuptake inhibitor, and is the first drug licensed for medical treatment of urodynamic stress incontinence. In this paper, we will briefly review the pharmacology, current evidence and controversies in relation to the use of duloxetine.
authors.affiliation: Department of Obstetrics and Gynaecology, Medway Maritime Hospital, Gillingham, UK.
authors.forename: M
authors.initials: M
authors.lastname: Basu
authors.forename: J
authors.initials: J
authors.lastname: Duckett
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000068736:Duloxetine Hydrochloride; D005260:Female; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D014550:Urinary Incontinence, Stress / Q000188:drug therapy*
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000068736:Duloxetine Hydrochloride; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes